The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Think the company is going to have to address this decline/short attack this week either by advising of a placing (get it over with) or saying in discussions and we envisage funding platform will not be an issue but we need to hear something.
I feel this move by the company to meet with a select group whom represent 16% of a large private shareholder base is very prudent indeed. IF they are in need of a vote to ward off a low ball bid getting private investors on board is extremely wise.
The only logical answer to what has been going on is the Chinese companies are ‘greasing the wheels’ far more. A few large donations and bulging brown envelopes, pure corruption at the highest level, an absolute disgrace for all the British diagnostic companies.
I see the 5-30mUK issue quite like this. The government has 25m of capacity tied up and if we get their contract we get this capacity. Another way we get some of this capacity is if the government relinquish some of it from their manufactures then we can buy up the capacity to add to our already signed up 5m capacity. Obviously we then have worldwide deals exciting times but will be glad to get some orders in to really underpin the share price.
Re ii - The info is all in the guidance notes you are guaranteed the 1/30 split shares you applied for at 2.7p any excess shares you applied for the cost has now been taken out of your account but you are not guaranteed the shares. You will hopefully receive a proportion of your excess plus a refund for the rest. Hope that clarifies things
Thought following Vox we had got rid of the boring paid derampers who actually know nothing about the company and have been fed one line to keep regurgitating . Mambo you seem a total **** and are now filtered
I work on the principal in Big Al we trust as if you don’t why are you invested? In one of his earlier interviews he touched on a capacity of 120pm I am hoping for this as even at £1 profit per test think what rocket that would put under our share price.
I also think it only a matter of time before big pharma comes sniffing £5 billion now or £25 billion in a couple of years. When looking at risk v reward for big pharma it is quite favourable as not just one shot boom/bust plenty of shots at goal. I will be very surprised if Avacta are still independent in 18 months time and hope they won’t be as I am the worlds worst at knowing when to sell so a takeover is perfect for me!
Or even thinking more left field the government are going to sell the sovereign test worldwide and maybe we receive higher royalties for rest of world and just sell everything we make to HMG. So many possibilities
25% up to your first £2381 which is equivalent to owning 238100 shares so there has been and probably will be a lot of forced sellers these next two days.
I imagine the IG effect has been huge here a lot of people will have been leveraged up as at 3p maximum downside was known. I had 10000 per point equivalent to 1 million shares and I suspect a lot of others were in the same boat and have been forced to close their positions this week. I was given four days notice by IG to have 100% margin by 26th Feb. The share will recover big time a contract would be nice!
Market makers loading up before a re-rate after forthcoming results when they will churn these back at a much higher price that’s my guess. With V prices up 12 days on a row hard to imagine anything other than good forward projections.
I expect to receive a special dividend instead of shares I would be surprised if Accustem ever came to market. Either a buyout by the firm presently with the market share to protect its position in the market or a rival firm wanting to get into the market. Existing firms would be foolish to let this firm develop and buying it now seems very logical. I would take £1 per share anything else a bonus